440 related articles for article (PubMed ID: 18824919)
1. Modulation of aquaporin-2/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge.
Chagnon F; Vaidya VS; Plante GE; Bonventre JV; Bernard A; Guindi C; Lesur O
Crit Care Med; 2008 Nov; 36(11):3054-61. PubMed ID: 18824919
[TBL] [Abstract][Full Text] [Related]
2. Acute renal response to the non-peptide vasopressin V2-receptor antagonist SR 121463B in anesthetized rats.
Huang DY; Pfaff I; Serradeil-Le Gal C; Vallon V
Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):201-7. PubMed ID: 10997721
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock.
Boffa JJ; Arendshorst WJ
J Am Soc Nephrol; 2005 Jan; 16(1):117-24. PubMed ID: 15563566
[TBL] [Abstract][Full Text] [Related]
4. Endothelin B receptors preserve renal blood flow in a normotensive model of endotoxin-induced acute kidney dysfunction.
Nitescu N; Grimberg E; Ricksten SE; Herlitz H; Guron G
Shock; 2008 Mar; 29(3):402-9. PubMed ID: 17693943
[TBL] [Abstract][Full Text] [Related]
5. Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits.
Albert M; Losser MR; Hayon D; Faivre V; Payen D
Crit Care Med; 2004 Sep; 32(9):1891-8. PubMed ID: 15343018
[TBL] [Abstract][Full Text] [Related]
6. Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.
Perucca J; Bichet DG; Bardoux P; Bouby N; Bankir L
J Am Soc Nephrol; 2008 Sep; 19(9):1721-31. PubMed ID: 18596120
[TBL] [Abstract][Full Text] [Related]
7. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
Bishara B; Shiekh H; Karram T; Rubinstein I; Azzam ZS; Abu-Saleh N; Nitecki S; Winaver J; Hoffman A; Abassi ZA
J Pharmacol Exp Ther; 2008 Aug; 326(2):414-22. PubMed ID: 18467593
[TBL] [Abstract][Full Text] [Related]
8. Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist.
Serradeil-Le Gal C
Adv Exp Med Biol; 1998; 449():427-38. PubMed ID: 10026834
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the urinary concentration defect and effect of desmopressin during endotoxemia in rats.
Versteilen AM; Heemskerk AE; Groeneveld AB; van Wijhe M; van Lambalgen AA; Tangelder GJ
Shock; 2008 Feb; 29(2):217-22. PubMed ID: 17693923
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Effects of Vasopressin Compared With Norepinephrine on Renal Perfusion, Oxygenation, and Function in Experimental Septic Acute Kidney Injury.
Okazaki N; Iguchi N; Evans RG; Hood SG; Bellomo R; May CN; Lankadeva YR
Crit Care Med; 2020 Oct; 48(10):e951-e958. PubMed ID: 32931198
[TBL] [Abstract][Full Text] [Related]
11. Renal water handling in rats with decompensated liver cirrhosis.
Jonassen TE; Christensen S; Kwon TH; Langhoff S; Salling N; Nielsen S
Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1101-9. PubMed ID: 11097629
[TBL] [Abstract][Full Text] [Related]
12. Effects of vasopressin and epinephrine on splanchnic blood flow and renal function during and after cardiopulmonary resuscitation in pigs.
Voelckel WG; Lindner KH; Wenzel V; Bonatti J; Hangler H; Frimmel C; Künszberg E; Lingnau W
Crit Care Med; 2000 Apr; 28(4):1083-8. PubMed ID: 10809287
[TBL] [Abstract][Full Text] [Related]
13. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.
Serradeil-Le Gal C; Lacour C; Valette G; Garcia G; Foulon L; Galindo G; Bankir L; Pouzet B; Guillon G; Barberis C; Chicot D; Jard S; Vilain P; Garcia C; Marty E; Raufaste D; Brossard G; Nisato D; Maffrand JP; Le Fur G
J Clin Invest; 1996 Dec; 98(12):2729-38. PubMed ID: 8981918
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of renal vasopressin V2 receptor and aquaporin-2 expression parallels age-associated defects in urine concentration.
Tian Y; Serino R; Verbalis JG
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F797-805. PubMed ID: 15213068
[TBL] [Abstract][Full Text] [Related]
15. Role of vasopressin V2 receptor in acute regulation of aquaporin-2.
Hayashi M; Sasaki S; Tsuganezawa H; Monkawa T; Kitajima W; Konishi K; Fushimi K; Marumo F; Saruta T
Kidney Blood Press Res; 1996; 19(1):32-7. PubMed ID: 8818115
[TBL] [Abstract][Full Text] [Related]
16. Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits.
Faivre V; Kaskos H; Callebert J; Losser MR; Milliez P; Bonnin P; Payen D; Mebazaa A
Anesthesiology; 2005 Sep; 103(3):514-21. PubMed ID: 16129976
[TBL] [Abstract][Full Text] [Related]
17. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats.
Ledderhos C; Mattson DL; Skelton MM; Cowley AW
Am J Physiol; 1995 Mar; 268(3 Pt 2):R796-807. PubMed ID: 7900923
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NF-kappaB ameliorates sepsis-induced downregulation of aquaporin-2/V2 receptor expression and acute renal failure in vivo.
Höcherl K; Schmidt C; Kurt B; Bucher M
Am J Physiol Renal Physiol; 2010 Jan; 298(1):F196-204. PubMed ID: 19828675
[TBL] [Abstract][Full Text] [Related]
19. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs.
Voelckel WG; Raedler C; Wenzel V; Lindner KH; Krismer AC; Schmittinger CA; Herff H; Rheinberger K; Königsrainer A
Crit Care Med; 2003 Apr; 31(4):1160-5. PubMed ID: 12682488
[TBL] [Abstract][Full Text] [Related]
20. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis.
Saito T; Higashiyama M; Nagasaka S; Sasaki S; Saito T; Ishikawa SE
Kidney Int; 2001 Oct; 60(4):1266-76. PubMed ID: 11576341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
